The 8 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 35.00 and a low estimate of 6.00. The median estimate represents a +15.61% increase from the last price of 8.65.
The current consensus among 9 polled investment analysts is to Hold stock in Inovio Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.25
Reporting Date Aug 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.